AMGEN Inc
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases and obesity and obesity-related conditions. Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
Profit margin of 21.0% — that's well above average.
Current Price
$347.94
-1.51%GoodMoat Value
$230.03
33.9% overvaluedAMGEN Inc (AMGN) Stock Chart
AMGN Interactive Stock Chart
Interactive stock chart for AMGEN Inc (AMGN) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $347.94. 52-week high: $388.16. 52-week low: $254.38. 50-day moving average: $362.37. 200-day moving average: $315.82.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for AMGN. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of AMGEN Inc's investment potential.